bioAffinity Technologies, Inc.
BIAF
$0.2872
-$0.0088-2.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.04% | -6.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.04% | -6.08% | |||
| Cost of Revenue | -12.44% | 8.47% | |||
| Gross Profit | -24.74% | -29.09% | |||
| SG&A Expenses | -16.02% | 23.50% | |||
| Depreciation & Amortization | 0.65% | 1.52% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.07% | 19.19% | |||
| Operating Income | 10.84% | -49.28% | |||
| Income Before Tax | 10.62% | -48.47% | |||
| Income Tax Expenses | -- | -100.00% | |||
| Earnings from Continuing Operations | 10.33% | -48.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.33% | -48.29% | |||
| EBIT | 10.84% | -49.28% | |||
| EBITDA | 8.02% | -53.24% | |||
| EPS Basic | 18.44% | -24.21% | |||
| Normalized Basic EPS | 18.74% | -24.40% | |||
| EPS Diluted | 18.44% | -24.21% | |||
| Normalized Diluted EPS | 18.74% | -24.40% | |||
| Average Basic Shares Outstanding | 9.94% | 19.34% | |||
| Average Diluted Shares Outstanding | 9.94% | 19.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||